AbbVie (ABBV)

$88.00 1.26 (1.41%)

19:59 EST ABBV Stock Quote Delayed 15 Minutes

Volume:

Previous Close $88.00

Market Cap 139.65B

PE Ratio 22.11

EPS 3.98

Volume (Avg. Vol.) 10.12M

Day's Range 87.79 - 89.27

52-Week Range 62.66 - 91.99

Dividend & Yield 3.59 (4.08%)

ABBV Stock Predictions, Articles, and AbbVie News

From InvestorPlace
From the Web

Beyond the Growing Dividend, Abbvie Stock Is a Good Buy Here

By Mark R. Hake, CFA Jan 16, 2020

Abbvie stock is a cheap high-yield dividend stock the market overlooks. The Allergan deal, closing shortly, will boost earnings and dividends and push Abbvie stock higher.

7 Great High-Yield Stocks With Payouts Over 5%

By Will Ashworth, InvestorPlace Contributor Jan 13, 2020

With the markets moving higher it’s harder to find high-yield stocks. Here are seven dividend stocks to consider that yield more than 5%.

7 Healthcare Stocks to Buy or Sell As Pricing Pressures Mount

By Ian Bezek, InvestorPlace Contributor Jan 10, 2020

Politicians have investors in healthcare stocks nervous as the 2020 election nears. Here's a guide to which firms are good choices and which you should avoid.

7 High-Yield Dividend Stocks Set for Growth

By Will Healy, InvestorPlace Contributor Jan 10, 2020

These seven dividend stocks come from diverse sectors of the economy, and they all offer high payouts and stock price growth.

Is Amarin Stock a Top Pick for 2020?

By Bret Kenwell, InvestorPlace Contributor Jan 6, 2020

Amarin stock has been on fire in 2019, but the reaction to its latest news was discouraging. Is that a buying opportunity or a warning sign?

7 High-Yield Dividend Stocks for Growth and Income in the 2020s

By Will Healy, InvestorPlace Contributor Dec 30, 2019

These dividend stocks yield considerable cash returns, and they will likely produce both payout and stock price increases in the 2020s.

Compare Brokers

5 Cheap High-Yield Dividend Stocks with Growing Dividends

By Mark R. Hake, CFA Dec 30, 2019

5 cheap high-yield dividend stocks with growing dividends. These five stocks have good dividend growth prospects along with high yields and low price-earnings ratios.

30 Marijuana Stocks to Buy as the Future Turns Green

By Josh Enomoto, InvestorPlace Contributor Dec 30, 2019

Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.

Stock Market Today: Amazon Breakout?; REIT Hate

By Bret Kenwell, InvestorPlace Contributor Dec 26, 2019

Amazon shares are breaking out and investors seem to hate REITs. Here's what happened in the stock market today.

5 Undervalued Stocks to Buy

By Chris Lau, InvestorPlace Contributor Dec 18, 2019

These undervalued stocks have been hit hard lately, but they still have what it takes to make a comeback, making them solid stocks to buy.

5 Large-Cap Dividend Stocks to Buy

By William Roth, InvestorPlace Market Strategist Dec 17, 2019

If you are on the lookout for large-cap dividend stocks to buy on the verge of a turnaround, here are five to consider.

5 Cheap Dividend Stocks With High Yields And Annual Increases

By Mark R. Hake, CFA Dec 13, 2019

5 cheap dividend stocks with high yields and annual increases. These dividend-paying stocks have high yields, low P/E ratios and consistently raise their dividends each year.

Compare Brokers

5 Great Dividend Stocks for Young Investors

By Chris Lau, InvestorPlace Contributor Nov 26, 2019

Dividend stocks are boring but predictable, but that doesn't mean young investors shouldn't look toward them to buy and hold forever.

Stock Market Today: General Electric Bears; Disney+ Bonanza

By Bret Kenwell, InvestorPlace Contributor Nov 13, 2019

General Electric stock has a bearish analyst, while Disney+ already hits 10 million subs. Here's what happened in the stock market today.

7 Biotech Stocks to Buy With Plenty of Power in the Pipeline

By Chris Lau, InvestorPlace Contributor Nov 12, 2019

With biotech stocks back in favor, investors may selectively pick only those with a deep drug pipeline ahead.

10 Medical Marijuana Stocks to Cure Your Portfolio

By Josh Enomoto, InvestorPlace Contributor Nov 8, 2019

Although recreational weed captures headlines, the real money is on broadly accepted medicinal marijuana stocks.

6 Top Stock Trades for Monday: BABA, PINS, CVX

By Bret Kenwell, InvestorPlace Contributor Nov 1, 2019

Alibaba, Pinterest, AbbVie, Chevron, U.S. Steel and Funko were our top stock trades to watch after a strong day Friday.

AbbVie Earnings: 5 Things for ABBV Stock Investors to Note

By William White, InvestorPlace Writer Nov 1, 2019

AbbVie (ABBV) earnings for the biopharmaceutical company's third quarter of 2019 have ABBV stock up Friday on an EPS and revenue beat.

Compare Brokers

3 Breakout Stocks to Buy for the Rest of 2019

By Nicolas Chahine, InvestorPlace Contributor Oct 31, 2019

The bulls have the advantage on Wall Street, so there are breakout stocks to buy into 2020. CVS, ABBV and SQ are three with bullish charts.

7 Buy-and-Hold Stocks to Play Investing’s Biggest Trends

By Josh Enomoto, InvestorPlace Contributor Oct 30, 2019

With economic and geopolitical events not providing clearly bullish signals, these buy-and-hold stocks present an ideal opportunity.

Like the majority of investors, you're most likely working on a retirement portfolio that will provide a large enough nest egg to give you a comfortable retirement. Make sure you know all about what financial planners call the accumulation and distribution phases of retirement planning.

Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates

From Zacks Investment Research Jan 17, 2020

Lilly (LLY) offers to buy Dermira for $1.1 billion. AstraZeneca (AZN) and AbbVie (ABBV) provide pipeline updates.

Navellier Ratings

Total Grade

Sell

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Welcome

Breaking news

AbbVie (ABBV)

Navellier Ratings

Total Grade

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Already a subscriber?

Welcome

Breaking news

AbbVie (ABBV)

ABBV Stock Predictions, Articles, and AbbVie News

Navellier Ratings

Total Grade

Subscriber Sign in